258 related articles for article (PubMed ID: 3114324)
1. Multiple sclerosis: relevance of class I and class II MHC-expressing cells to lesion development.
Traugott U
J Neuroimmunol; 1987 Oct; 16(2):283-302. PubMed ID: 3114324
[TBL] [Abstract][Full Text] [Related]
2. Multiple sclerosis. Distribution of T cells, T cell subsets and Ia-positive macrophages in lesions of different ages.
Traugott U; Reinherz EL; Raine CS
J Neuroimmunol; 1983 Jun; 4(3):201-21. PubMed ID: 6222066
[TBL] [Abstract][Full Text] [Related]
3. Interferon-gamma and Ia antigen are present on astrocytes in active chronic multiple sclerosis lesions.
Traugott U; Lebon P
J Neurol Sci; 1988 Apr; 84(2-3):257-64. PubMed ID: 3132537
[TBL] [Abstract][Full Text] [Related]
4. On the presence of Ia-positive endothelial cells and astrocytes in multiple sclerosis lesions and its relevance to antigen presentation.
Traugott U; Scheinberg LC; Raine CS
J Neuroimmunol; 1985 Apr; 8(1):1-14. PubMed ID: 3882754
[TBL] [Abstract][Full Text] [Related]
5. Endothelial cell class II major histocompatibility complex molecule expression in stereotactic brain biopsies of patients with acute inflammatory/demyelinating conditions.
van der Maesen K; Hinojoza JR; Sobel RA
J Neuropathol Exp Neurol; 1999 Apr; 58(4):346-58. PubMed ID: 10218630
[TBL] [Abstract][Full Text] [Related]
6. Dual-label immunocytochemistry of the active multiple sclerosis lesion: major histocompatibility complex and activation antigens.
Hayashi T; Morimoto C; Burks JS; Kerr C; Hauser SL
Ann Neurol; 1988 Oct; 24(4):523-31. PubMed ID: 3266456
[TBL] [Abstract][Full Text] [Related]
7. Multiple sclerosis. Evidence for antigen presentation in situ by endothelial cells and astrocytes.
Traugott U; Raine CS
J Neurol Sci; 1985 Jul; 69(3):365-70. PubMed ID: 3897464
[TBL] [Abstract][Full Text] [Related]
8. Immunocytochemical characterisation of the immune reaction in the central nervous system in multiple sclerosis. Possible role for microglia in lesion growth.
Woodroofe MN; Bellamy AS; Feldmann M; Davison AN; Cuzner ML
J Neurol Sci; 1986 Jul; 74(2-3):135-52. PubMed ID: 3488371
[TBL] [Abstract][Full Text] [Related]
9. Human astrocytes are only partially competent antigen presenting cells. Possible implications for lesion development in multiple sclerosis.
Weber F; Meinl E; Aloisi F; Nevinny-Stickel C; Albert E; Wekerle H; Hohlfeld R
Brain; 1994 Feb; 117 ( Pt 1)():59-69. PubMed ID: 7511974
[TBL] [Abstract][Full Text] [Related]
10. HLA class II molecules (HLA-DR, -DP, -DQ) on cells in the human CNS studied in situ and in vitro.
Ulvestad E; Williams K; Bø L; Trapp B; Antel J; Mørk S
Immunology; 1994 Aug; 82(4):535-41. PubMed ID: 7835916
[TBL] [Abstract][Full Text] [Related]
11. Expression of the immune-tolerogenic major histocompatibility molecule HLA-G in multiple sclerosis: implications for CNS immunity.
Wiendl H; Feger U; Mittelbronn M; Jack C; Schreiner B; Stadelmann C; Antel J; Brueck W; Meyermann R; Bar-Or A; Kieseier BC; Weller M
Brain; 2005 Nov; 128(Pt 11):2689-704. PubMed ID: 16123145
[TBL] [Abstract][Full Text] [Related]
12. Immunoregulatory molecules and IL 2 receptors identified in multiple sclerosis brain.
Hofman FM; von Hanwehr RI; Dinarello CA; Mizel SB; Hinton D; Merrill JE
J Immunol; 1986 May; 136(9):3239-45. PubMed ID: 3082983
[TBL] [Abstract][Full Text] [Related]
13. Microglia are the major cell type expressing MHC class II in human white matter.
Hayes GM; Woodroofe MN; Cuzner ML
J Neurol Sci; 1987 Aug; 80(1):25-37. PubMed ID: 3302117
[TBL] [Abstract][Full Text] [Related]
14. Characterization of two distinct primary T cell populations that secrete interleukin 2 upon recognition of class I or class II major histocompatibility antigens.
Mizuochi T; Ono S; Malek TR; Singer A
J Exp Med; 1986 Mar; 163(3):603-19. PubMed ID: 2936862
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical analysis of the cellular infiltrate in multiple sclerosis lesions.
Hauser SL; Bhan AK; Gilles F; Kemp M; Kerr C; Weiner HL
Ann Neurol; 1986 Jun; 19(6):578-87. PubMed ID: 3524414
[TBL] [Abstract][Full Text] [Related]
16. IL-2 receptor and HLA class II antigens on cerebrospinal fluid cells of patients with multiple sclerosis and other neurological diseases.
Tournier-Lasserve E; Lyoncaen O; Roullet E; Bach MA
Clin Exp Immunol; 1987 Mar; 67(3):581-6. PubMed ID: 3038441
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of transcription factors controlling MHC expression in multiple sclerosis lesions.
Gobin SJ; Montagne L; Van Zutphen M; Van Der Valk P; Van Den Elsen PJ; De Groot CJ
Glia; 2001 Oct; 36(1):68-77. PubMed ID: 11571785
[TBL] [Abstract][Full Text] [Related]
18. Multiple sclerosis: a role for astroglia in active demyelination suggested by class II MHC expression and ultrastructural study.
Lee SC; Moore GR; Golenwsky G; Raine CS
J Neuropathol Exp Neurol; 1990 Mar; 49(2):122-36. PubMed ID: 2307980
[TBL] [Abstract][Full Text] [Related]
19. HLA-DR4-IE chimeric class II transgenic, murine class II-deficient mice are susceptible to experimental allergic encephalomyelitis.
Ito K; Bian HJ; Molina M; Han J; Magram J; Saar E; Belunis C; Bolin DR; Arceo R; Campbell R; Falcioni F; Vidović D; Hammer J; Nagy ZA
J Exp Med; 1996 Jun; 183(6):2635-44. PubMed ID: 8676084
[TBL] [Abstract][Full Text] [Related]
20. Immune system associated antigens expressed by cells of the human central nervous system.
Luber-Narod J; Rogers J
Neurosci Lett; 1988 Nov; 94(1-2):17-22. PubMed ID: 3266526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
